scispace - formally typeset
Y

Yesi Shi

Researcher at Xiamen University

Publications -  14
Citations -  441

Yesi Shi is an academic researcher from Xiamen University. The author has contributed to research in topics: Immunology & Medicine. The author has an hindex of 7, co-authored 10 publications receiving 187 citations. Previous affiliations of Yesi Shi include Guangxi Medical University.

Papers
More filters
Journal ArticleDOI

Fe(III)-Porphyrin Sonotheranostics: A Green Triple-Regulated ROS Generation Nanoplatform for Enhanced Cancer Imaging and Therapy

TL;DR: This sonotheranostics significantly enhances the SDT effect of porphyrin through the cancer‐targeted delivery capability and enhanced reactive oxygen species production via triple‐regulated approaches, including down‐regulation of SOD2, depletion of glutathione, and generation of Fenton reaction.
Journal ArticleDOI

Genetically engineered magnetic nanocages for cancer magneto-catalytic theranostics

TL;DR: The inherent excellent magnetic-heat capability, coupled with catalysis-triggered tumor suppression, allows eMIONs to provide an MRI-guided magneto-catalytic combination therapy, which may open up a new avenue for bench-to-bed translational research of MHT.
Journal ArticleDOI

A Self-Assembled α-Synuclein Nanoscavenger for Parkinson’s Disease

TL;DR: A simple and efficient strategy for fabricating the α-syn nanoscavenger for PD via a reprecipitation self-assembly procedure is developed, which provides a clinically translatable therapeutic strategy aimed at neuroprotection and disease modification in PD.
Journal ArticleDOI

TRAIL-expressing cell membrane nanovesicles as an anti-inflammatory platform for rheumatoid arthritis therapy

TL;DR: This work proposed and validated a nanoparticle-based broad-spectrum anti-inflammatory strategy for RA management by fusing TRAIL-anchored cell membranes onto drug-loaded polymeric cores (TU-NPs), which makes them ideal decoys of inflamed macrophage-targeted biological molecules.
Journal ArticleDOI

Tumor microenvironment-triggered MoS2@GA-Fe nanoreactor: A self-rolling enhanced chemodynamic therapy and hydrogen sulfide treatment for hepatocellular carcinoma

TL;DR: The TME-responsive “Fenton Nanoreactor” provides a promising strategy with enhanced translational potency for tumor therapy and an imaging-guided chemodynamic treatment, featuring excellent antitumor efficiency and biosafety.